Bank of Montreal
CHRS icon

Bank of Montreal’s Coherus Oncology CHRS Stock Holding History

Bank of Montreal’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,000
Closed -$72K – 4167
2017
Q2 		$72K Buy
+5,000
New +$96.2K ﹤0.01% 3093

Other funds holding CHRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Bank of Montreal's CHRS Position: Q1 2025 in Review

Bank of Montreal sold out of Coherus Oncology (CHRS) in Q1 2025, closing a stake of 24,690 shares — an estimated $34.1K sold.

Bank of Montreal first reported a position in CHRS in Q3 2016 and held it in 22 quarters. The position peaked at $14.2M in Q3 2021. 117 funds tracked by Wall St. Rank hold CHRS as of Q1 2025.

  • Bank of Montreal reported no remaining Coherus Oncology position as of Q1 2025 after selling out during the quarter.
  • Bank of Montreal sold 24,690 Coherus Oncology shares in Q1 2025, an estimated $34.1K.
  • Bank of Montreal first reported a position in Coherus Oncology in Q3 2016 and held it in 22 quarters.
  • Bank of Montreal's Coherus Oncology position peaked at $14.2M in Q3 2021.
  • 117 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2025.

Based on Bank of Montreal's 13F filing for Q1 2025, filed 13 May 2025.